Search research articles
Contact Us
Filters
Showing results (341-350 of 464) with videos related to
Page
of 47
Sort By:
The American Journal of Gastroenterology
|
September 16, 2022
Rapid and Sustained Symptom Relief in Patients With Ulcerative Colitis Treated With Filgotinib: Data From the Phase 2b/3 SELECTION Trial
Silvio Danese, Marc Ferrante, Brian G Feagan, et al.
Gastroenterology
|
July 5, 2011
Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis
Jean Frédéric Colombel, Paul Rutgeerts, Walter Reinisch, et al.
The New England Journal of Medicine
|
August 23, 2013
Vedolizumab as induction and maintenance therapy for ulcerative colitis
Brian G Feagan, Paul Rutgeerts, Bruce E Sands, et al.
Gastroenterology
|
July 15, 2009
Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximab
William J Sandborn, Paul Rutgeerts, Brian G Feagan, et al.
The New England Journal of Medicine
|
August 23, 2013
Vedolizumab as induction and maintenance therapy for Crohn's disease
William J Sandborn, Brian G Feagan, Paul Rutgeerts, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
September 2, 2019
Reliability of Endoscopic Evaluation of Postoperative Recurrent Crohn's Disease
Christopher Ma, Krisztina B Gecse, Marjolijn Duijvestein, et al.
The American Journal of Gastroenterology
|
May 9, 2020
Incorporating Fecal Calprotectin Into Clinical Practice for Patients With Moderate-to-Severely Active Ulcerative Colitis Treated With Biologics or Small-Molecule Inhibitors
Parambir S Dulai, Robert Battat, Maria Barsky, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
August 6, 2025
A Phase 2 Study of MORF-057, an Oral α4β7 Integrin Inhibitor in Moderately to Severely Active Ulcerative Colitis
Bruce E Sands, Stefan Schreiber, Silvio Danese, et al.
The New England Journal of Medicine
|
September 29, 2021
Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis
William J Sandborn, Brian G Feagan, Geert D'Haens, et al.
Journal of Crohn'S & Colitis
|
November 9, 2025
Placebo rates in randomized clinical trials of ulcerative colitis: an individual patient data meta-analysis
Virginia Solitano, Malcolm Hogan, Siddharth Singh, et al.
Page
of 47
Search research articles
Search
Showing results (341-350 of 464) with videos related to
Sort By:
Page
of 47
The American Journal of Gastroenterology
|
September 16, 2022
Rapid and Sustained Symptom Relief in Patients With Ulcerative Colitis Treated With Filgotinib: Data From the Phase 2b/3 SELECTION Trial
Silvio Danese, Marc Ferrante, Brian G Feagan, et al.
Gastroenterology
|
July 5, 2011
Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis
Jean Frédéric Colombel, Paul Rutgeerts, Walter Reinisch, et al.
The New England Journal of Medicine
|
August 23, 2013
Vedolizumab as induction and maintenance therapy for ulcerative colitis
Brian G Feagan, Paul Rutgeerts, Bruce E Sands, et al.
Gastroenterology
|
July 15, 2009
Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximab
William J Sandborn, Paul Rutgeerts, Brian G Feagan, et al.
The New England Journal of Medicine
|
August 23, 2013
Vedolizumab as induction and maintenance therapy for Crohn's disease
William J Sandborn, Brian G Feagan, Paul Rutgeerts, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
September 2, 2019
Reliability of Endoscopic Evaluation of Postoperative Recurrent Crohn's Disease
Christopher Ma, Krisztina B Gecse, Marjolijn Duijvestein, et al.
The American Journal of Gastroenterology
|
May 9, 2020
Incorporating Fecal Calprotectin Into Clinical Practice for Patients With Moderate-to-Severely Active Ulcerative Colitis Treated With Biologics or Small-Molecule Inhibitors
Parambir S Dulai, Robert Battat, Maria Barsky, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
August 6, 2025
A Phase 2 Study of MORF-057, an Oral α4β7 Integrin Inhibitor in Moderately to Severely Active Ulcerative Colitis
Bruce E Sands, Stefan Schreiber, Silvio Danese, et al.
The New England Journal of Medicine
|
September 29, 2021
Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis
William J Sandborn, Brian G Feagan, Geert D'Haens, et al.
Journal of Crohn'S & Colitis
|
November 9, 2025
Placebo rates in randomized clinical trials of ulcerative colitis: an individual patient data meta-analysis
Virginia Solitano, Malcolm Hogan, Siddharth Singh, et al.
Page
of 47